These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1315533)

  • 1. Fucoidan is a non-anticoagulant inhibitor of intimal hyperplasia.
    McCaffrey TA; Falcone DJ; Borth W; Brayton CF; Weksler BB
    Biochem Biophys Res Commun; 1992 Apr; 184(2):773-81. PubMed ID: 1315533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of transforming growth factor-beta 1 activity by heparin and fucoidan.
    McCaffrey TA; Falcone DJ; Vicente D; Du B; Consigli S; Borth W
    J Cell Physiol; 1994 Apr; 159(1):51-9. PubMed ID: 7511146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferative activity and alpha-smooth muscle actin expression in cultured rat aortic smooth muscle cells are differently modulated by transforming growth factor-beta 1 and heparin.
    Orlandi A; Ropraz P; Gabbiani G
    Exp Cell Res; 1994 Oct; 214(2):528-36. PubMed ID: 7925646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of heparin to inhibit intimal hyperplasia in injured baboon arteries. The role of heparin-sensitive and -insensitive pathways in the stimulation of smooth muscle cell migration and proliferation.
    Geary RL; Koyama N; Wang TW; Vergel S; Clowes AW
    Circulation; 1995 Jun; 91(12):2972-81. PubMed ID: 7796508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for an age-related dysfunction in the antiproliferative response to transforming growth factor-beta in vascular smooth muscle cells.
    McCaffrey TA; Falcone DJ
    Mol Biol Cell; 1993 Mar; 4(3):315-22. PubMed ID: 8387357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fucoidan inhibits smooth muscle cell proliferation and reduces mitogen-activated protein kinase activity.
    Religa P; Kazi M; Thyberg J; Gaciong Z; Swedenborg J; Hedin U
    Eur J Vasc Endovasc Surg; 2000 Nov; 20(5):419-26. PubMed ID: 11112459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low molecular weight fucoidan prevents intimal hyperplasia in rat injured thoracic aorta through the modulation of matrix metalloproteinase-2 expression.
    Hlawaty H; Suffee N; Sutton A; Oudar O; Haddad O; Ollivier V; Laguillier-Morizot C; Gattegno L; Letourneur D; Charnaux N
    Biochem Pharmacol; 2011 Jan; 81(2):233-43. PubMed ID: 20887714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different action of heparin and fucoidan on arterial smooth muscle cell proliferation and thrombospondin and fibronectin metabolism.
    Vischer P; Buddecke E
    Eur J Cell Biol; 1991 Dec; 56(2):407-14. PubMed ID: 1802722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antimitogenic action of the sulphated polysaccharide fucoidan differs from heparin in human vascular smooth muscle cells.
    Patel MK; Mulloy B; Gallagher KL; O'Brien L; Hughes AD
    Thromb Haemost; 2002 Jan; 87(1):149-54. PubMed ID: 11848445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of human endothelial cell proliferation and migration by fucoidan and heparin.
    Giraux JL; Matou S; Bros A; Tapon-Bretaudière J; Letourneur D; Fischer AM
    Eur J Cell Biol; 1998 Dec; 77(4):352-9. PubMed ID: 9930660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rat vascular smooth muscle cells immortalized with SV40 large T antigen possess defined smooth muscle cell characteristics including growth inhibition by heparin.
    Reilly CF
    J Cell Physiol; 1990 Feb; 142(2):342-51. PubMed ID: 2154504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. I. Comparison with heparin for antiproliferative activity, binding and internalization.
    Logeart D; Prigent-Richard S; Jozefonvicz J; Letourneur D
    Eur J Cell Biol; 1997 Dec; 74(4):376-84. PubMed ID: 9438134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin inhibits SMC growth in the presence of human and fetal bovine serum.
    Cindhuchao N; Quinn DA; Garg HG; Hales CA
    Biochem Biophys Res Commun; 2003 Feb; 302(1):84-8. PubMed ID: 12593851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin decreases the rate of proliferation of rat vascular smooth muscle cells by releasing transforming growth factor beta-like activity from serum.
    Grainger DJ; Witchell CM; Watson JV; Metcalfe JC; Weissberg PL
    Cardiovasc Res; 1993 Dec; 27(12):2238-47. PubMed ID: 8313434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A crosstalk between TGF-β/Smad3 and Wnt/β-catenin pathways promotes vascular smooth muscle cell proliferation.
    DiRenzo DM; Chaudhary MA; Shi X; Franco SR; Zent J; Wang K; Guo LW; Kent KC
    Cell Signal; 2016 May; 28(5):498-505. PubMed ID: 26912210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin inhibition of human vascular smooth muscle cell hyperplasia.
    Chan P; Mill S; Mulloy B; Kakkar V; Demoliou-Mason C
    Int Angiol; 1992; 11(4):261-7. PubMed ID: 1338338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Galphaq in smooth muscle cell proliferation.
    Tanski WJ; Roztocil E; Hemady EA; Williams JA; Davies MG
    J Vasc Surg; 2004 Mar; 39(3):639-44. PubMed ID: 14981460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin and cilazapril together inhibit injury-induced intimal hyperplasia.
    Clowes AW; Clowes MM; Vergel SC; Müller RK; Powell JS; Hefti F; Baumgartner HR
    Hypertension; 1991 Oct; 18(4 Suppl):II65-9. PubMed ID: 1833326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cyclolignan picropodophyllin attenuates intimal hyperplasia after rat carotid balloon injury by blocking insulin-like growth factor-1 receptor signaling.
    Razuvaev A; Henderson B; Girnita L; Larsson O; Axelson M; Hedin U; Roy J
    J Vasc Surg; 2007 Jul; 46(1):108-15. PubMed ID: 17606126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen replacement inhibits intimal hyperplasia and the accumulation and effects of transforming growth factor beta1.
    Selzman CH; Gaynor JS; Turner AS; Whitehill TA; Horwitz LD; Harken AH
    J Surg Res; 1998 Dec; 80(2):380-5. PubMed ID: 9878341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.